Home » Topics » BioWorld Science

BioWorld Science
RSS

Janssen discovers novel potent EP inhibitors

May 19, 2020

Incyte presents novel PI3K-gamma inhibitors

May 19, 2020

Human L-opsin gene therapy shows potential for treating blue cone monochromacy

May 19, 2020

Heron Therapeutics initiates phase Ib/II study of HTX-034 for postoperative pain

May 19, 2020

Intermediary results presented for VLP COVID-19 vaccine in mice

May 19, 2020

LATS2 and KIBRA are prognostic markers in patients with ccRCC

May 19, 2020

FDA clears IND application for phase II study of merimepodib in advanced COVID-19

May 19, 2020

Namodenoson reduces liver fat and fibrosis in phase II NAFLD study

May 19, 2020

Cellect's ApoGraft to be studied for treatment of COVID-19-related pulmonary diseases

May 19, 2020

Interim phase I data presented for mRNA-1273 coronavirus vaccine

May 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...